Aarti Drugs

Aarti Drugs

527.60
-10.15
(-1.89%)
Market Cap
4,815.40 Cr
EPS
18.35
PE Ratio
25.67
Dividend Yield
0.19 %
Industry
Healthcare
52 Week High
635.00
52 Week Low
312.00
PB Ratio
3.54
Debt to Equity
0.47
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from1 analysts
HOLD
Analysts have suggested that investors can hold this stock
Buy
Buy0.0 %
0.0 %
Hold
Hold+100.00 %
+100.00 %
Sell
Sell0.0 %
0.0 %

Company News

View All News
Caret
positive
Aarti Drugs Limited reported quarterly revenue growth of 6% year-on-year to INR591 crores, driven by a 5% growth in API business volumes. The company achieved gross profit margin improvement of 130 basis points to 36.8% and EBITDA growth of 12% to INR74 crores with margins at 12.6%. The improvement was attributed to normalization of input costs. The company's greenfield project at Sayakha Gujarat has started trial production for anti-diabetic products backward integration. The Tarapur facility for salicylic acid production faced initial startup issues but is expected to contribute from Q3 FY26, with current output below 200 tonnes per month targeting 800 tonnes soon. Formulation business grew 14% to INR80 crores with 57% from exports. The company received USFDA approval for its oncology facility and UK MHRA approval for oral solid dosage facility. Management expects capex of INR150-200 crores for FY26 and targets 15% CAGR volume growth over FY26-27. Net debt stands at INR597 crores with debt-to-equity ratio of 0.42-0.43.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,702.20
#1 4,08,414.80
35.66
#1 54,729.00
12.06
#1 10,980
-18.99
55.97
6,584.00
1,74,784.50
79.73
9,712.00
0.89
2,191
23.05
40.37
1,572.00
1,26,971.70
23.53
28,409.50
7.12
5,291
9.88
70.77
3,622.90
1,22,615.40
60.75
11,539.40
6.99
1,911
19.91
72.46
1,287.40
1,07,442.70
#1 18.90
33,741.20
16.73
5,725
1.26
54.50
2,541.60
1,04,899.10
60.41
12,744.20
19.57
2,007
-10.91
52.39
980.10
98,621.00
21.20
23,511.00
13.82
4,615
-0.19
54.96
1,960.50
89,535.10
27.57
22,909.50
#1 19.94
3,306
#1 112.49
53.75
32,895.00
69,899.60
49.39
6,684.70
10.80
1,414
27.83
42.22
1,127.00
65,456.30
18.95
31,378.10
17.55
3,366
-0.50
47.15

Automatic Screeners on ScanX

Forecast
Actual
Growth Rate
Revenue Growth
-6.83 %
Net Income Growth
3.12 %
Cash Flow Change
169.22 %
ROE
-4.01 %
ROCE
-6.00 %
EBITDA Margin (Avg.)
11.75 %

Quarterly Financial Results

Quarterly Financials
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
283
273
265
314
292
316
291
299
258
319
336
332
375
348
380
464
406
478
474
459
546
578
533
503
582
580
642
697
622
688
665
743
662
642
608
621
557
600
569
679
591
Expenses
240
230
226
269
244
265
247
253
223
267
282
274
322
300
328
403
351
409
410
378
411
462
425
421
500
506
545
608
555
614
593
649
577
565
536
534
490
531
495
583
516
EBITDA
44
42
40
45
48
51
43
46
36
53
54
57
54
47
52
61
55
69
64
81
135
117
108
82
81
74
97
89
67
74
72
94
85
77
72
87
66
69
74
95
74
Operating Profit %
15 %
16 %
15 %
14 %
16 %
16 %
15 %
16 %
14 %
16 %
16 %
17 %
14 %
14 %
14 %
12 %
13 %
14 %
13 %
16 %
25 %
20 %
20 %
16 %
14 %
13 %
14 %
12 %
11 %
11 %
11 %
13 %
13 %
12 %
12 %
14 %
12 %
11 %
11 %
14 %
13 %
Depreciation
9
9
9
9
10
10
10
9
10
10
10
10
10
11
11
11
12
12
12
13
12
13
13
12
12
13
13
13
13
13
13
13
13
13
13
14
13
14
14
15
15
Interest
10
11
11
12
10
9
9
9
9
8
9
9
9
10
11
10
9
9
8
8
7
7
5
4
4
5
5
6
7
9
9
9
9
8
8
9
9
9
9
9
9
Profit Before Tax
25
23
23
25
29
33
24
31
17
35
35
38
34
27
31
40
34
48
43
61
116
97
90
65
65
56
79
71
48
53
50
73
64
56
52
64
44
46
51
71
51
Tax
8
7
6
6
9
11
6
9
5
11
12
14
10
9
10
12
11
16
15
2
31
22
22
14
16
14
20
15
13
14
13
17
16
17
15
17
11
11
14
8
-3
Net Profit
17
16
17
19
20
22
18
22
11
24
23
24
23
18
21
27
23
32
28
59
85
75
68
52
49
43
58
55
35
39
37
56
48
40
37
47
33
35
37
63
54
EPS in ₹
7.18
6.49
7.03
7.68
8.21
9.11
7.56
8.70
4.77
9.89
9.78
9.97
9.82
7.65
8.86
12.06
9.56
13.87
11.92
25.26
9.17
8.08
7.30
5.54
5.25
4.60
6.29
5.97
3.76
4.18
3.96
6.07
5.18
4.29
3.99
5.15
3.62
3.83
4.06
6.88
5.91

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
1,002
1,102
1,191
1,389
1,456
1,577
1,766
2,208
2,421
2,432
2,575
Fixed Assets
449
493
581
602
625
644
665
690
676
811
1,196
Current Assets
526
565
571
737
784
900
1,057
1,393
1,492
1,321
1,338
Capital Work in Progress
16
34
14
28
33
12
19
77
210
261
330
Investments
0
0
12
11
12
13
17
20
19
20
473
Other Assets
537
575
584
748
785
907
1,064
1,422
1,516
1,340
0
Total Liabilities
1,002
1,102
1,191
1,389
1,456
1,577
1,766
2,208
2,421
2,432
2,575
Current Liabilities
483
501
494
622
591
623
595
940
950
796
837
Non Current Liabilities
211
244
297
312
321
301
257
232
279
355
368
Total Equity
308
357
400
455
543
653
913
1,036
1,193
1,282
1,369
Reserve & Surplus
284
333
376
432
520
629
820
944
1,100
1,190
1,278
Share Capital
24
24
24
24
24
23
93
93
93
92
91

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-1
1
-0
0
1
2
2
13
-14
-1
Investing Activities
-107
-99
-107
-74
-62
-33
-72
-150
-164
-224
Operating Activities
105
133
175
70
143
251
155
70
133
359
Financing Activities
2
-33
-68
4
-80
-215
-81
92
17
-136

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
60.20 %
60.14 %
60.12 %
59.99 %
59.83 %
59.98 %
59.77 %
59.66 %
59.58 %
58.70 %
58.56 %
57.47 %
57.13 %
55.67 %
55.64 %
55.38 %
55.48 %
55.22 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
2.33 %
2.10 %
2.56 %
2.96 %
2.50 %
2.28 %
2.25 %
2.26 %
DIIs
1.59 %
1.97 %
2.09 %
2.28 %
2.69 %
2.76 %
3.16 %
3.90 %
4.09 %
4.71 %
5.32 %
5.26 %
5.99 %
7.35 %
7.84 %
8.77 %
9.70 %
9.94 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
31.86 %
32.32 %
32.68 %
32.85 %
32.02 %
32.16 %
26.66 %
25.98 %
25.72 %
25.34 %
24.65 %
25.84 %
25.11 %
24.75 %
24.80 %
24.32 %
23.51 %
23.69 %
Others
6.36 %
5.57 %
5.11 %
4.89 %
5.46 %
5.10 %
10.41 %
10.46 %
10.61 %
11.25 %
9.14 %
9.33 %
9.20 %
9.27 %
9.21 %
9.24 %
9.06 %
8.89 %
No of Share Holders
1,73,704
1,77,992
1,83,344
1,95,469
1,89,607
1,86,674
1,80,303
1,73,283
1,69,090
1,62,409
1,67,446
1,70,414
1,57,547
1,50,218
1,90,281
1,76,006
1,69,761
1,60,260

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 1 1 1 2 2.5 1 1 1 0.00
Dividend Yield (%) 0.00 0.79 0.63 0.8 0.29 0.58 0.3 0.23 0.29 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
18 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
18 Jul 2025 480.75 515.75
06 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 May 2025 351.65 355.05
04 Feb 2025 DIVIDEND Dividend
₹ 1.00 /share
04 Feb 2025 390.15 423.40
29 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
29 Jan 2025 424.35 390.15
24 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
24 Oct 2024 504.35 488.25
20 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
20 Sept 2024 582.80 518.60
06 Feb 2024 DIVIDEND Dividend
₹ 1.00 /share
06 Feb 2024 535.45 519.95
08 Feb 2023 DIVIDEND Dividend
₹ 1.00 /share
08 Feb 2023 406.10 393.45
10 Feb 2022 DIVIDEND Dividend
₹ 1.00 /share
09 Feb 2022 497.60 525.00
01 Oct 2020 BONUS Bonus
3:1
30 Sept 2020 741.84 771.30

Announcements

Announcement under Regulation 30 (LODR)-Earnings Call Transcript3 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome7 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication9 days ago
Announcement under Regulation 30 (LODR)-Investor Presentation9 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release10 days ago
Appointment Of Secretarial Auditor10 days ago
Board Meeting Outcome for Audited Standalone And Consolidated Financial Results For The Quarter Ended June 30 2025 And Outcome Of The Meeting Of The Board Of Directors Held On July 18 202510 days ago
Financial Results For The Quarter Ended June 30 202510 days ago
Reply To The Clarification Sought With Respect To Increase In The Volume Of Security Across The ExchangeJul 16, 2025
Clarification sought from Aarti Drugs LtdJul 16, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 15, 2025
Board Meeting Intimation for Audited Financial Results For The Quarter Ended June 30 2025.Jul 15, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 12, 2025
Closure of Trading WindowJun 27, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 14, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 22, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 12, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 08, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 07, 2025
Disclosure Under Regulation 30 - Ad-Interim Order By The CourtMay 07, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 06, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 06, 2025
Board Meeting Outcome for Financial Results For The Quarter And Year Ended March 31 2025 And Appointment Of Cost AuditorMay 06, 2025
Outcome Of The Board Meeting And Financial Results For The Quarter And Year Ended March 31 2025May 06, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 29, 2025
Board Meeting Intimation for Audited Financial Results For The Quarter And Year Ended March 31 2025Apr 29, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 08, 2025
Disclosure Under Regulation 30 Of SEBI Listing RegulationsApr 02, 2025
Closure of Trading WindowMar 29, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 11, 2025
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 ("Listing Regulations")Mar 07, 2025
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 ("Listing Regulations") - Action Taken Or Order PassedMar 06, 2025
Announcement Under Regulation 30 Of Listing Regulations - ESG RatingMar 03, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 28, 2025
Disclosure Under Reg 30 Of Listing Regulations - Update On Lifting Of Import Alert 66-40 By US DFAFeb 14, 2025
Disclosure Under Regulation 30 Of Listing Reguations- Order Of CGST And C.Ex. AuthorityFeb 07, 2025
Disclosure Under Regulation 30 Of Listing Regulations-Feb 05, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 04, 2025
Announcement under Regulation 30 (LODR)-AcquisitionFeb 04, 2025
Announcement under Regulation 30 (LODR)-AcquisitionFeb 03, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 31, 2025
Announcement under Regulation 30 (LODR)-Credit RatingJan 31, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJan 30, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationJan 29, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 29, 2025
Announcement under Regulation 30 (LODR)-AcquisitionJan 29, 2025
Integrated Filing (Financial)Jan 29, 2025

Technical Indicators

RSI(14)
Neutral
62.98
ATR(14)
Less Volatile
20.27
STOCH(9,6)
Neutral
69.92
STOCH RSI(14)
Neutral
60.10
MACD(12,26)
Bullish
2.52
ADX(14)
Strong Trend
43.88
UO(9)
Bearish
49.30
ROC(12)
Uptrend But Slowing Down
10.53
WillR(14)
Neutral
-37.97